Searched for
DRUG DEVELOPMENT
Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery pushAnthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to imp...- USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'The facility belongs to Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma. The US Food and Drug Administration (...
- Congress rolls out 'Punjab Mangda Insaaf' campaign ahead of state pollsThe Punjab Congress initiated its 'Punjab Mangda Insaaf' campaign to connect with people across the state. Leaders Pargat Singh and Partap ...
- Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAFollowing an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Vol...
- Drugmakers tap China AI app boom to reach doctors as crackdown upends marketingAs scrutiny intensifies, Chinese pharmaceutical companies are shifting gears toward digital marketing initiatives. Traditional face-to-face...
- Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
- GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...
- Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDAEli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (U...
- NCLT approves Ashdan Properties' resolution plan for Sunblink Real EstateThe National Company Law Tribunal approved Ashdan Properties' resolution plan for Sunblink Real Estate, which involved significant creditor...
- Home Minister Amit Shah sets December 2028 drug-free Gujarat target, a year ahead of national deadlineUnion Home Minister Amit Shah on Monday set December 31, 2028, as the deadline to make Gujarat drug-free, a year ahead of India’s December ...
- Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
- Scientists gave mice an existing asthma drug before exposing them to peanut extract; 95% were protected from severe allergic reactions in the experimentResearchers at Northwestern University found that the asthma drug Zileuton reduces allergic reactions in mice fed peanut extract. The study...
- AI investment cycle may have peaked, Jefferies warns; raises India allocation to 14%According to a recent Jefferies report, global investment in artificial intelligence appears to be facing a mid-cycle correction. Although ...
- OpenAI to acquire developer tools firm Pierre to expand Codex capabilitiesOpenAI will acquire Pierre Computer Company, the developer of open-source coding tools, to expand its Codex platform's capabilities in buil...
- With most drug candidates failing in humans, India’s draft rules bet on the wrong science in animal lab testingRecent draft rules in India threaten advancements in non-animal testing for drug development and safety. The new regulations may prioritize...
- ‘Punjab’s remote control is in Delhi’: Rahul Gandhi attacks AAP, Bhagwant Mann over drugs; challenges PM for an open debateRahul Gandhi held an 'Insaaf Rally' in Sangrur, where he criticized the Aam Aadmi Party's governance in Punjab. He questioned Chief Ministe...
- Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...
- Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...
- Anthropic's Claude cut Enveda's drug records' review time by 89%Colorado-based biotechnology company Enveda developed a CMC Document Processor to help reviewers identify errors, inconsistencies and poten...
- AI halves drug discovery times, but =trial bottleneck remains a costly realityNovo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory a...
Load More
